Braizon Therapeutics, Inc.

Braizon Therapeutics, Inc.

Biotechnology Research 3 Chome-42-1 Hongo, Bunkyo-ku 5 employees
Employees
5
Contacts
2
Emails
2

Braizon Therapeutics, Inc. Overview

Headquarters
3 Chome-42-1 Hongo, Bunkyo-ku
Phone Number
Available in AeroLeads
Website
braizon.com
Industry
Biotechnology Research
Employees
5
Founded
2015
Funding
9.5M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Braizon Therapeutics, Inc.

Braizon Therapeutics, Inc. is working to solve the blood brain barrier problem for oligonucleotide therapeutics, removing the need for spinal cord injections to treat neurological disorders. Our Brain Access platform utilizes novel IP combining polymer nanoparticles with proven targeting methods for targeting therapies to the brain to create IV formulations for our partners. This platform is under development for expansion into small molecule, peptide, and antibody drug delivery into the brain. HQ'd in Tokyo, Braizon has US operations in Cambridge, MA. enabling our experienced team to offer partnering worldwide for biotech and Pharma with a strategic focus on neurology.

Braizon Therapeutics, Inc. Contact Details

People in AeroLeads
2
With contact data
2
Email contacts
2
100.0% coverage

Braizon Therapeutics, Inc. Org Chart

Sample employees and titles
Name Title Contact
Mariko Tosu Braizon Therapeutics, Inc. - founder
Email
Philip Davy Business Development Executive
Email

Employees by Management Level

Individual contributor 2 profiles
Executive 1 profile
Manager 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 1 1 0

Compare Similar Companies to Braizon Therapeutics, Inc.